Article
Molecular characterization of multidrug-resistant tuberculosis against levofloxacin, moxifloxacin, bedaquiline, linezolid, clofazimine, and delamanid in southwest of China.
BMC infectious diseases - 8 Apr 2021
Zheng Huiwen, He Wencong, Jiao Weiwei, Xia Hui, Sun Lin, Wang Shengfen, Xiao Jing, Ou Xichao, Zhao Yanlin, Shen Adong
Abstract excerpt
OBJECTIVES: To explore the drug susceptibility of levofloxacin (LFX), moxifloxacin (MFX), bedaquiline (BDQ), linezolid (LZD), clofazimine (CFZ) and delamanid (DLM) against multidrug resistant tuberculosis (MDR-TB) isolates from drug resistance survey of southwest China, and to illustrate the genetic characteristics of MDR-TB isolates with acquired drug resistance. METHODS: A total of 339 strains were collected...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
